KOVACEVIC, A., A. OHMAN, G. TULZER, U. HERBERG, J. DANGEL, J.S. CARVALHO, V. FESSLOVA, Hana JIČÍNSKÁ, T. SARKOLA, C. PEDROZA, I.E. AVERISS, M. MELLANDER and H.M. GARDINER. Fetal hemodynamic response to aortic valvuloplasty and postnatal outcome: a European multicenter study. ULTRASOUND IN OBSTETRICS & GYNECOLOGY. HOBOKEN: WILEY-BLACKWELL, 2018, vol. 52, No 2, p. 221-229. ISSN 0960-7692. Available from: https://dx.doi.org/10.1002/uog.18913.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Fetal hemodynamic response to aortic valvuloplasty and postnatal outcome: a European multicenter study
Authors KOVACEVIC, A. (826 United Kingdom of Great Britain and Northern Ireland), A. OHMAN (752 Sweden), G. TULZER (40 Austria), U. HERBERG (276 Germany), J. DANGEL (616 Poland), J.S. CARVALHO (826 United Kingdom of Great Britain and Northern Ireland), V. FESSLOVA (380 Italy), Hana JIČÍNSKÁ (203 Czech Republic, belonging to the institution), T. SARKOLA (246 Finland), C. PEDROZA (840 United States of America), I.E. AVERISS (840 United States of America), M. MELLANDER (752 Sweden) and H.M. GARDINER (840 United States of America, guarantor).
Edition ULTRASOUND IN OBSTETRICS & GYNECOLOGY, HOBOKEN, WILEY-BLACKWELL, 2018, 0960-7692.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30214 Obstetrics and gynaecology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.595
RIV identification code RIV/00216224:14110/18:00104181
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/uog.18913
UT WoS 000440665400013
Keywords in English aortic stenosis; fetal therapy; fetus; Norwood procedure
Tags 14110317, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 10/2/2019 13:05.
Abstract
Objective Fetal aortic stenosis may progress to hypoplastic left heart syndrome. Fetal valvuloplasty (FV) has been proposed to improve left heart hemo-dynamics and maintain biventricular (BV) circulation. The aim of this study was to assess FV efficacy by comparing survival and postnatal circulation between fetuses that underwent FV and those that did not. Methods This was a retrospective multicenter study of fetuses with aortic stenosis that underwent FV between 2005 and 2012, compared with contemporaneously enrolled natural history (NH) cases sharing similar characteristics at presentation but not undergoing FV. Main outcome measures were overall survival, BV-circulation survival and survival after birth. Secondary outcomes were hemodynamic change and left heart growth. A propensity score model was created including 54/67 FV and 60/147 NH fetuses. Analyses were performed using logistic, Cox or linear regression models with inverse probability of treatment weighting (IPTW) restricted to fetuses with a propensity score of 0.14-0.9, to create a final cohort for analysis of 42 FV and 29 NH cases. Results FV was technically successful in 59/67 fetuses at a median age of 26 (21-34) weeks. There were 7/72 10%) procedure-related losses, and 22/53 (42%) FV babies were delivered at < 37 weeks. IPTW demonstrated improved survival of liveborn infants following FV (hazard ratio, 0.38; 95% CI, 0.23-0.64; P = 0.0001), after adjusting for circulation and postnatal surgical center. Similar proportions had BV circulation (36% for the FV cohort and 38% for the NH cohort) and survival was similar between final circulations. Successful FV cases showed improved hemodynamic response and less deterioration of left heart growth compared with NH cases (P <= 0.01). Conclusions We report improvements in fetal hemodynamics and preservation of left heart growth following successful FV compared with NH. While the proportion of those achieving a BV circulation outcome was similar in both cohorts, FV survivors showed improved survival independent of final circulation to 10 years' follow-up. However, FV is associated with a 10% procedure-related loss and increased prematurity compared with the NH cohort, and therefore the risk-to-benefit ratio remains uncertain. We recommend a carefully designed trial incorporating appropriate and integrated fetal and postnatal management strategies to account for center-specific practices, so that the benefits achieved by fetal therapy vs surgical strategy can be demonstrated clearly. Copyright (C) 2017 ISUOG. Published by John Wiley & Sons Ltd.
PrintDisplayed: 23/7/2024 18:22